Sosei Heptares to Regain Worldwide Rights to Muscarinic Agonist Programs ...Middle East

PR Newswire - News
TOKYO and CAMBRIDGE, England, Jan. 5, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) announces it is to regain the worldwide rights to its muscarinic agonist programs. The program was licensed to Allergan in April 2016, and Allergan was acquired by AbbVie in May...

Hence then, the article about sosei heptares to regain worldwide rights to muscarinic agonist programs was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sosei Heptares to Regain Worldwide Rights to Muscarinic Agonist Programs )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News